Literature DB >> 16542164

Immunophenotypic patterns of T-cell activation in neuroinflammatory diseases.

A Heinrich1, N Ahrens, S Schmidt, A V Khaw.   

Abstract

OBJECTIVES: We aimed to gain insights into the pathogen-specific differences in early adaptive immune responses following central nervous system infections with Borrelia burgdorferi and viral pathogens by studying the immunophenotypic patterns of T-cell activation. Moreover, we wished to determine whether the expression of T-cell activation markers reflects disease activity in multiple sclerosis (MS).
METHODS: Proportions of cerebrospinal fluid T-cells expressing the markers HLA-DR, CD25 and CD38 were determined in patients with MS (n = 40), acute viral meningomyeloradiculoneuritis (VID, n = 26), early neuroborreliosis (NB, n = 23) and non-inflammatory neurologic diseases (n = 51) by using flow cytometry. In relapsing-remitting MS, disease activity was assessed by clinical examination and magnetic resonance imaging.
RESULTS: For each of the surface markers that were examined, significant differences in T cell proportions were found between patient groups. The proportion of HLA-DR+ T cells was higher and that of CD25+ T cells lower in NB compared with VID. These differences were attributable only to the early phase of the disease (< or = 6 days after symptom onset). Among MS patients, there was a trend for higher proportions of T cells expressing activation markers in patients with gadolinium-enhancing lesions.
CONCLUSIONS: The decreased CD25 expression in NB may reflect immunomodulatory effects of B. burgdorferi facilitating persistent infection. Larger prospective studies of T-cell activation markers for ascertaining the association between cellular markers and clinical surrogates of disease activity in MS are warranted.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16542164     DOI: 10.1111/j.1600-0404.2005.00562.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  4 in total

1.  Comprehensive immunophenotyping of cerebrospinal fluid cells in patients with neuroimmunological diseases.

Authors:  Sungpil Han; Yen Chih Lin; Tianxia Wu; Alan D Salgado; Ina Mexhitaj; Simone C Wuest; Elena Romm; Joan Ohayon; Raphaela Goldbach-Mansky; Adeline Vanderver; Adriana Marques; Camilo Toro; Peter Williamson; Irene Cortese; Bibiana Bielekova
Journal:  J Immunol       Date:  2014-02-07       Impact factor: 5.422

2.  Dynamic changes of MMP-9 plasma levels correlate with JCV reactivation and immune activation in natalizumab-treated multiple sclerosis patients.

Authors:  Marco Iannetta; Maria Antonella Zingaropoli; Tiziana Latronico; Ilaria Pati; Simona Pontecorvo; Carla Prezioso; Valeria Pietropaolo; Antonio Cortese; Marco Frontoni; Claudia D'Agostino; Ada Francia; Vincenzo Vullo; Claudio Maria Mastroianni; Grazia Maria Liuzzi; Maria Rosa Ciardi
Journal:  Sci Rep       Date:  2019-01-22       Impact factor: 4.379

3.  Immunophenotypic lymphocyte profiles in human african trypanosomiasis.

Authors:  Caroline Boda; Bertrand Courtioux; Pierre Roques; Lynda Pervieux; Gédéon Vatunga; Théophile Josenando; Constant Roger Ayenengoye; Bernard Bouteille; Marie-Odile Jauberteau; Sylvie Bisser
Journal:  PLoS One       Date:  2009-07-08       Impact factor: 3.240

4.  Classification of neurological diseases using multi-dimensional CSF analysis.

Authors:  Catharina C Gross; Andreas Schulte-Mecklenbeck; Lohith Madireddy; Marc Pawlitzki; Christine Strippel; Saskia Räuber; Julia Krämer; Leoni Rolfes; Tobias Ruck; Carolin Beuker; Antje Schmidt-Pogoda; Lisa Lohmann; Tilman Schneider-Hohendorf; Tim Hahn; Nicholas Schwab; Jens Minnerup; Nico Melzer; Luisa Klotz; Sven G Meuth; Gerd Meyer Zu Hörste; Sergio E Baranzini; Heinz Wiendl
Journal:  Brain       Date:  2021-10-22       Impact factor: 13.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.